Pain Management Drugs Market To Reach New Heights
Pain Management Drugs Market is estimated to reach from $58,577 million in 2016, $77,131 million by 2023. It is anticipated to register a CAGR of 4% during the forecast period, 2017-2023. Pain is a distressing sensory and emotional feeling, which occurs due to tissue damage or illness.
Pain Management Drugs Market is estimated to reach from $58,577 million in 2016, $77,131 million by 2023. It is anticipated to register a CAGR of 4% during the forecast period, 2017-2023. Pain is a distressing sensory and emotional feeling, which occurs due to tissue damage or illness.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Pain</strong> <strong>Management</strong> <strong>Drugs</strong> <strong>Market</strong><br />
Global<br />
Opportunity<br />
Analysis and<br />
Industry Forecast,<br />
2017-2023<br />
Opportunity Analysis and Industry Forecast, 2016-2023
Introductionof<br />
<strong>Pain</strong> <strong>Management</strong> <strong>Drugs</strong> <strong>Market</strong><br />
❑ The pain management drugs market accounted for $58,577 million in 2016, and is<br />
estimated to reach $77,131 million by 2023, registering a CAGR of 4% from 2017 to<br />
2023. North America was the highest contributor to the pain management drugs<br />
market in 2016; however, Asia-Pacific is expected to witness the highest growth<br />
rate during the forecast period.<br />
❑ <strong>Pain</strong> is a complex medical condition, which not only affects the physical but also<br />
mental well-being of an individual. It is caused due to trauma or tissue damage,<br />
and its intensity varies from person to person. Based on the cause of pain, the<br />
treatment provided can be a simple or complex. <strong>Pain</strong> can be managed with the<br />
help of a variety of pharmacological and non-pharmacological therapies.<br />
❑ Increase in prevalence of cancer and rise in number of surgeries conducted per<br />
year have fueled the demand for nonsteroidal anti-inflammatory drugs, and opioids<br />
in the market, thereby driving the market growth. As per the statistics provided by<br />
the World Bank, almost 4,511.1 surgeries were conducted per 100,000 population<br />
in 2012, which is further expected to supplement the market growth.
Introductionof<br />
<strong>Pain</strong> <strong>Management</strong> <strong>Drugs</strong> <strong>Market</strong><br />
Scope of the Report<br />
Key Benefits<br />
Key Audiences
Key Benefits<br />
1. It entails a detailed quantitative analysis of the current market trends to identify<br />
the prevailing opportunities, during the period, 2016- 2023.<br />
2. It offers market estimations on the basis of comprehensive analysis of the key<br />
developments in the industry.<br />
3. It provides in-depth assessment of the market with respect to drug class,<br />
indication, and geography.<br />
4. It enlists the development strategies adopted by key manufacturers to<br />
understand the competitive scenario of the market.<br />
Click to Access Full Summary of <strong>Pain</strong> <strong>Management</strong> <strong>Drugs</strong> <strong>Market</strong>
Table of Content (TOC)<br />
Chapter: 1 Introduction<br />
Chapter: 2 Executive Summary<br />
Chapter: 3 <strong>Market</strong> Overview<br />
Chapter: 4 <strong>Pain</strong> <strong>Management</strong> <strong>Drugs</strong> <strong>Market</strong>, By Drug Type<br />
Chapter: 5 <strong>Pain</strong> <strong>Management</strong> <strong>Drugs</strong> <strong>Market</strong>, By Indication<br />
Chapter: 6 <strong>Pain</strong> <strong>Management</strong> <strong>Drugs</strong> <strong>Market</strong>, By Geography<br />
Chapter 8: Company Profiles
Segments<br />
<strong>Pain</strong> <strong>Management</strong> <strong>Drugs</strong> <strong>Market</strong><br />
By Drug<br />
Class<br />
Segments<br />
By<br />
Indication
Segments<br />
<strong>Pain</strong> <strong>Management</strong> <strong>Drugs</strong> <strong>Market</strong><br />
NSAIDs<br />
Opioids<br />
Anesthetics<br />
By Drug<br />
Class<br />
Antidepressants<br />
Anticonvuls<br />
ants<br />
Antimigraine<br />
Agents
Segments<br />
<strong>Pain</strong> <strong>Management</strong> <strong>Drugs</strong> <strong>Market</strong><br />
Arthritic<br />
<strong>Pain</strong><br />
Fibromyalgia<br />
Neuropathic<br />
<strong>Pain</strong><br />
Migraine<br />
By<br />
Indication<br />
Cancer <strong>Pain</strong><br />
Postoperative<br />
<strong>Pain</strong><br />
Chronic Back<br />
<strong>Pain</strong>
Company Profiles<br />
<strong>Pain</strong> <strong>Management</strong> <strong>Drugs</strong> <strong>Market</strong><br />
1. NOVARTIS AG<br />
2. ELI LILLY & COMPANY<br />
3. ABBOTT LABORATORIES, INC.<br />
4. ENDO HEALTH SOLUTIONS, INC.<br />
5. PURDUE PHARMA L.P.<br />
6. PFIZER, INC.
Thank You<br />
<strong>Pain</strong> <strong>Management</strong> <strong>Drugs</strong> <strong>Market</strong><br />
ThankYou!<br />
For More Details<br />
Do Enquiry<br />
https://www.alliedmarketresearch.com/pain-management-therapeutics-market<br />
Follow Us On
Change language